Search

everythinglearnresearchcommunity

for

Search:↓

SPRY1 deficiency in skin cells causes stem cells to move to the skin surface, leading to increased pigmentation.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Transgenic sheep cells with spider silk gene were successfully created for future sheep hair expression.

Human skin cells with stem-like features can help create new hair follicles and sebaceous glands when combined with other cells.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

ePUKs could be valuable for regenerative medicine due to their wound healing abilities.

POUF51 and HES3 are key in controlling stem cell numbers in psoriasis.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Suplatast tosilate successfully treated a woman's systemic sclerosis symptoms.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

VSELs may hold the key to longer life through regenerative therapies.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

The document concludes that pig iPSCs show promise for transplant therapies and the field is advancing in controlling cell behavior for biology and medicine.

Early-stage skin substitutes improve wound healing and skin structure.

Blocking TGFβ-RI signaling enhances surface ectoderm differentiation from human stem cells.

The gelatin/β-TCP scaffold with nanoparticles improves wound healing and skin regeneration.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

LL-37 helps stem cells grow and move, aiding tissue regeneration and hair growth.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

The method effectively delivers vaccines through the skin without needles.